We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+4.1%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.02%
AUM
$1.99B
AUM Growth
+$284M
Cap. Flow
+$258M
Cap. Flow %
12.95%
Top 10 Hldgs %
13.22%
Holding
2,248
New
441
Increased
650
Reduced
654
Closed
492

Sector Composition

Rank Sector Weight
1 Technology 15.96%
2 Consumer Discretionary 13.01%
3 Healthcare 12.59%
4 Industrials 12.57%
5 Financials 11.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESNT icon
1676
Essent Group
ESNT
$6.15B
$35K ﹤0.01%
991
-22,496
-96% -$815K
SIRI icon
1677
SiriusXM
SIRI
$10.2B
$35K ﹤0.01%
510
-4,792
-90% -$324K
TDG icon
1678
TransDigm Group
TDG
$71.9B
$35K ﹤0.01%
100
-2,030
-95% -$667K
S
1679
DELISTED
Sprint Corporation
S
$35K ﹤0.01%
+6,500
New +$35.2K
EIDX
1680
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$34K ﹤0.01%
+1,665
New +$34.9K
CMP icon
1681
Compass Minerals
CMP
$1.21B
$33K ﹤0.01%
500
-700
-58% -$46.6K
VSLR
1682
DELISTED
VIVINT SOLAR, INC.
VSLR
$33K ﹤0.01%
+6,620
New +$27.7K
ANW
1683
DELISTED
Aegean Marine Petroleum Network
ANW
$33K ﹤0.01%
49,171
+20,747
+73% +$45.9K
STIM icon
1684
Neuronetics
STIM
$150M
$32K ﹤0.01%
+1,200
New +$32.6K
AUD
1685
DELISTED
Audacy, Inc.
AUD
$32K ﹤0.01%
4,300
+700
+19% +$5.94K
NTGN
1686
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$32K ﹤0.01%
+2,500
New +$34.2K
NDLS icon
1687
Noodles & Co
NDLS
$111M
$31K ﹤0.01%
+310
New +$21.9K
RES icon
1688
RPC Inc
RES
$1.28B
$31K ﹤0.01%
2,134
-29,481
-93% -$504K
BTU icon
1689
Peabody Energy
BTU
$2.65B
$30K ﹤0.01%
659
-38,828
-98% -$1.59M
ESL
1690
DELISTED
Esterline Technologies
ESL
$30K ﹤0.01%
400
-1,486
-79% -$110K
MRSN
1691
DELISTED
Mersana Therapeutics
MRSN
$29K ﹤0.01%
+65
New +$28.5K
TRVN
1692
DELISTED
Trevena, Inc.
TRVN
$29K ﹤0.01%
+32
New +$35.2K
DATA
1693
DELISTED
Tableau Software, Inc.
DATA
$29K ﹤0.01%
300
-27,349
-99% -$2.51M
BEAT
1694
DELISTED
BioTelemetry, Inc.
BEAT
$29K ﹤0.01%
+654
New +$26.1K
TRGP icon
1695
Targa Resources
TRGP
$56.8B
$28K ﹤0.01%
561
-18,846
-97% -$896K
TNDM icon
1696
Tandem Diabetes Care
TNDM
$1.38B
$27K ﹤0.01%
+1,210
New +$14.9K
MGY icon
1697
Magnolia Oil & Gas
MGY
$5.96B
$26K ﹤0.01%
+2,400
New +$25K
NMM icon
1698
Navios Maritime Partners
NMM
$2.31B
$26K ﹤0.01%
+910
New +$24.8K
SRRA
1699
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$25K ﹤0.01%
213
-143
-40% -$14.3K
PBYI icon
1700
Puma Biotechnology
PBYI
$391M
$24K ﹤0.01%
400
-702
-64% -$40.7K

Similar funds

Cubist Systematic Strategies's Q2 2018 Portfolio in Review

As of Q2 2018, Cubist Systematic Strategies held 2,248 positions worth $1.99B, up 17% from $1.71B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Cubist Systematic Strategies deployed $258M of net new capital in Q2 2018, opening 441 new positions and adding to 650 existing holdings. Its largest new stake was Sage Therapeutics: 76,110 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $59.2M trimmed.

  • Cubist Systematic Strategies's largest Q2 2018 buy was Sage Therapeutics: 76,110 shares worth $11.9M.
  • Cubist Systematic Strategies added most to ZENDESK INC in Q2 2018, an estimated $10.8M increase.
  • Cubist Systematic Strategies's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $59.2M.
  • Cubist Systematic Strategies fully exited TJX Companies in Q2 2018, selling an estimated $6.46M.
  • Cubist Systematic Strategies's ten largest holdings make up 13% of its $1.99B portfolio in Q2 2018.
  • Cubist Systematic Strategies opened 441 new positions and closed 492 in Q2 2018.
  • Cubist Systematic Strategies's portfolio value rose 17% quarter-over-quarter to $1.99B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2018, filed 14 Aug 2018.